Literature DB >> 24974380

Chalazia associated with bortezomib therapy for multiple myeloma.

Seanna R Grob1, Frederick A Jakobiec2, Alia Rashid2, Michael K Yoon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24974380     DOI： 10.1016/j.ophtha.2014.04.021

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  3 in total

1.  Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions.

Authors:  Chen Fu; Dan S Gombos; Jared Lee; Goldy C George; Kenneth Hess; Andrew Whyte; David S Hong
Journal:  Oncotarget       Date:  2017-05-05

2.  Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series.

Authors:  Bonnie A Sklar; Kalla A Gervasio; Siyang Leng; Arnab Ghosh; Ajai Chari; Albert Y Wu
Journal:  BMC Ophthalmol       Date:  2019-05-14       Impact factor: 2.209

3.  Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy.

Authors:  Charles Yun; Nikhil Mukhi; Valerie Kremer; Roman Shinder; Vaibhav Verma; Batuman Olcay
Journal:  Hematol Rep       Date:  2015-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.